Bracebridge Capital LLC’s Aquestive Therapeutics AQST Stock Holding History

Bracebridge Capital LLC’s Portfolio AQST Stock Details AQST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.91M	Hold	459,216	–	–	0.03%	25
2026 Q1	$1.91M	Hold	459,216	–	–	0.05%	30
2025 Q4	$2.97M	Hold	459,216	–	–	0.1%	19
2025 Q3	$2.57M	Hold	459,216	–	–	0.13%	20
2025 Q2	$1.52M	Hold	459,216	–	–	0.08%	30
2025 Q1	$1.33M	Hold	459,216	–	–	0.09%	21
2024 Q4	$1.63M	Buy	459,216 +30,645	+7%	+$141K	0.12%	24
2024 Q3	$2.13M	Hold	428,571	–	–	0.35%	15
2024 Q2	$1.11M	Hold	428,571	–	–	0.2%	12
2024 Q1	$1.83M	Hold	428,571	–	–	0.23%	14
2023 Q4	$866K	Hold	428,571	–	–	0.19%	13
2023 Q3	$656K	Hold	428,571	–	–	0.1%	14
2023 Q2	$707K	Hold	428,571	–	–	0.39%	20
2023 Q1	$489K	Hold	428,571	–	–	0.13%	39
2022 Q4	$387K	Hold	428,571	–	–	0.04%	65
2022 Q3	$501K	Hold	428,571	–	–	0.09%	82
2022 Q2	$274K	Hold	428,571	–	–	0.04%	86
2022 Q1	$1.12M	Hold	428,571	–	–	0.08%	68
2021 Q4	$1.67M	Hold	428,571	–	–	0.1%	60
2021 Q3	$1.87M	Hold	428,571	–	–	0.17%	50
2021 Q2	$1.7M	Hold	428,571	–	–	0.15%	47
2021 Q1	$2.23M	Hold	428,571	–	–	0.19%	33
2020 Q4	$2.29M	Hold	428,571	–	–	0.35%	13
2020 Q3	$2.08M	Hold	428,571	–	–	0.33%	11
2020 Q2	$2.08M	Hold	428,571	–	–	0.61%	10
2020 Q1	$1M	Hold	428,571	–	–	0.18%	11
2019 Q4	$2M	Buy	+428,571	New	+$2.23M	0.16%	13

Other funds holding AQST

BCM

Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Bracebridge Capital LLC's AQST Position: Q2 2026 in Review

Bracebridge Capital LLC held its Aquestive Therapeutics (AQST) position steady in Q2 2026 at 459,216 shares worth $1.91M. The position accounts for 0.03% of the portfolio, ranked #25.

Bracebridge Capital LLC first reported a position in AQST in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.97M in Q4 2025. 185 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

Bracebridge Capital LLC held 459,216 shares of Aquestive Therapeutics worth $1.91M as of Q2 2026.
Bracebridge Capital LLC left its Aquestive Therapeutics share count unchanged in Q2 2026.
Aquestive Therapeutics made up 0.03% of Bracebridge Capital LLC's portfolio in Q2 2026, its #25 holding.
Bracebridge Capital LLC first reported a position in Aquestive Therapeutics in Q4 2019 and has held it in 27 quarters since.
Bracebridge Capital LLC's Aquestive Therapeutics position peaked at $2.97M in Q4 2025.
185 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Bracebridge Capital LLC's 13F filing for Q2 2026, filed 14 Aug 2026.